These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 4034582

  • 21. Chemotherapy of advanced prostatic cancer today.
    Murphy GP, Merrin CE.
    Prog Clin Biol Res; 1976; 6():285-99. PubMed ID: 139614
    [No Abstract] [Full Text] [Related]

  • 22. Carcinoma of the prostate.
    Abercrombie GF.
    Ann R Coll Surg Engl; 1974 Jan; 54(1):16-21. PubMed ID: 4129191
    [No Abstract] [Full Text] [Related]

  • 23. Hormonal therapy of advanced prostatic cancer.
    Fair WR.
    J Urol; 1986 Sep; 136(3):653-4. PubMed ID: 2942708
    [No Abstract] [Full Text] [Related]

  • 24. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
    Bollack C, Rougeron G.
    Am J Clin Oncol; 1988 Sep; 11 Suppl 2():S156-9. PubMed ID: 2977270
    [Abstract] [Full Text] [Related]

  • 25. External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy.
    Takada C, Ito K, Nishi J, Yamamoto T, Hatanaka Y, Baba Y, Takahashi M.
    Radiat Med; 1995 Sep; 13(6):297-300. PubMed ID: 8850371
    [Abstract] [Full Text] [Related]

  • 26. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB, Lindner A.
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [Abstract] [Full Text] [Related]

  • 27. [Experiences with Honvan therapy in carcinoma of the prostate].
    Joó GD.
    Med Welt; 1966 Jan 01; 1():61-4. PubMed ID: 5942368
    [No Abstract] [Full Text] [Related]

  • 28. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul 01; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 29. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May 01; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 30. Hormone therapy in cancer.
    Kennedy BJ.
    Geriatrics; 1970 Oct 01; 25(10):106-12. PubMed ID: 4096937
    [No Abstract] [Full Text] [Related]

  • 31. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug 06; 24(615):74. PubMed ID: 7099111
    [No Abstract] [Full Text] [Related]

  • 32. Primary metastatic carcinoma of the prostate in younger men: a plea to think over usual therapeutic strategies.
    Maier U, Höbarth K, Simak R.
    Eur Urol; 1996 Aug 06; 29(2):221-3. PubMed ID: 8647151
    [Abstract] [Full Text] [Related]

  • 33. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
    Galsky MD, Small EJ, Oh WK, Chen I, Smith DC, Colevas AD, Martone L, Curley T, Delacruz A, Scher HI, Kelly WK.
    J Clin Oncol; 2005 Mar 01; 23(7):1439-46. PubMed ID: 15735119
    [Abstract] [Full Text] [Related]

  • 34. [Principles for the conservative drug therapy treatment of prostate cancer].
    Hofmann W.
    Z Urol Nephrol; 1981 Sep 01; 74(9):697-704. PubMed ID: 7314992
    [No Abstract] [Full Text] [Related]

  • 35. Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
    Noguchi M, Itoh K, Suekane S, Morinaga A, Sukehiro A, Suetsugu N, Katagiri K, Yamada A, Noda S.
    Prostate; 2004 Jun 15; 60(1):32-45. PubMed ID: 15129427
    [Abstract] [Full Text] [Related]

  • 36. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F, Esposti PL, Andersson L.
    Scand J Urol Nephrol Suppl; 1980 Jun 15; 55():139-42. PubMed ID: 6938017
    [Abstract] [Full Text] [Related]

  • 37. [Hormonotherapy of so-called solid tumors].
    Cappelaere P.
    Sem Hop; 1972 Jan 20; 48(4):279-82. PubMed ID: 4338349
    [No Abstract] [Full Text] [Related]

  • 38. [Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
    Carstensen HE, Olsen CE, Sele V, Brorson I, Jensen E, Nissen NI, Fabricius J.
    Nord Med; 1969 Jan 23; 81(4):111-4. PubMed ID: 4888811
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J, Shukla SK, Chu TM, Mittelman A, Murphy GP.
    Invest Urol; 1974 Jul 23; 12(1):65-8. PubMed ID: 4835492
    [No Abstract] [Full Text] [Related]

  • 40. Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer.
    Pienta KJ, Smith DC.
    Semin Oncol; 1997 Oct 23; 24(5 Suppl 15):S15-72-S15-77. PubMed ID: 9346227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.